Atorvastatin Calcium
Product Images NDC 45865-727

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 45865-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (727)

Atorvastatin Calcium Tablets 40 mg packaging label from medsource pharmaceuticals, generic for Lipitor. The label shows identification numbers, dosage strength, form (white oval tablets), and advises checking with a doctor before use. It includes the manufacturer name, TEVA PHARM. IND. LTD., located in Jerusalem, Israel, and provides warnings about alcohol consumption with this medicine.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tabs Form I A205300 1)

Chemical structure of Atorvastatin Calcium, depicting the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion complexed with three water molecules, corresponding to the atorvastatin calcium trihydrate form.*

FDA Label Image

Figure 1 (Atorvastatin Calcium Tabs Form I A205300 2)

A line graph depicting cumulative incidence percentage over a period of up to 3.5 years, comparing Atorvastatin and placebo groups. The Atorvastatin group shows a lower cumulative incidence than the placebo group. The graph includes a hazard ratio (HR) of 0.64 (0.50 to 0.83) with a p-value of 0.0005.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tabs Form I A205300 3)

A line graph comparing the cumulative hazard percentage over time up to five years for Atorvastatin versus placebo. The x-axis represents time in years to the first primary endpoint, and the y-axis represents cumulative hazard percentage. Two curves are shown: a solid line for Atorvastatin and a dashed line for placebo, indicating lower cumulative hazard with Atorvastatin across the follow-up period.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tabs Form I A205300 4)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (years) for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio data (HR 0.78, P=0.0002).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.